People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nortis Inc | — | Biotechnology | Series A | $18.0M | $78.7M | 2021 |
Greg Corona at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Greg Corona on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL CONLEY | 1 | 17 |
| Susan Preston | 1 | 4 |
| Walter L. Robb | 1 | 4 |
| Alan C. Nelson | 1 | 2 |
| Makoto Shintani | 1 | 2 |
| Sharon K. Everson | 1 | 2 |
| Thomas Neumann | 1 | 1 |
| Thomas L. Neumann | 1 | 1 |
| Kriss L. Hammond | 1 | 1 |
| Mary Ellen Harrison | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.